Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
Identifieur interne : 001502 ( PascalFrancis/Corpus ); précédent : 001501; suivant : 001503Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
Auteurs : Dedee F. Murrell ; Benjamin S. Daniel ; Pascal Joly ; Luca Borradori ; Masayuki Amagai ; Takashi Hashimoto ; Frederic Caux ; Branka Marinovic ; Animesh A. Sinha ; Michael Hertl ; Philippe Bernard ; David Sirois ; Giuseppe Cianchini ; Janet A. Fairley ; Marcel F. Jonkman ; Amit G. Pandya ; David Rubenstein ; Detlef Zillikens ; Aimee S. Payne ; David Woodley ; Giovanna Zambruno ; Valeria Aoki ; Carlo Pincelli ; Luis Diaz ; Russell P. Hall ; Michael Meurer ; Jose M. Jr Mascaro ; Enno Schmidt ; Hiroshi Shimizu ; John Zone ; Robert Swerlick ; Daniel Mimouni ; Donna Culton ; Jasna Lipozencic ; Benjamin Bince ; Sergei A. Grando ; Jean-Claude Bystryn ; Victoria P. WerthSource :
- Journal of the American Academy of Dermatology [ 0190-9622 ] ; 2012.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
|
|---|
Format Inist (serveur)
| NO : | PASCAL 12-0153002 INIST |
|---|---|
| ET : | Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts |
| AU : | MURRELL (Dedee F.); DANIEL (Benjamin S.); JOLY (Pascal); BORRADORI (Luca); AMAGAI (Masayuki); HASHIMOTO (Takashi); CAUX (Frederic); MARINOVIC (Branka); SINHA (Animesh A.); HERTL (Michael); BERNARD (Philippe); SIROIS (David); CIANCHINI (Giuseppe); FAIRLEY (Janet A.); JONKMAN (Marcel F.); PANDYA (Amit G.); RUBENSTEIN (David); ZILLIKENS (Detlef); PAYNE (Aimee S.); WOODLEY (David); ZAMBRUNO (Giovanna); AOKI (Valeria); PINCELLI (Carlo); DIAZ (Luis); HALL (Russell P.); MEURER (Michael); MASCARO (Jose M. JR); SCHMIDT (Enno); SHIMIZU (Hiroshi); ZONE (John); SWERLICK (Robert); MIMOUNI (Daniel); CULTON (Donna); LIPOZENCIC (Jasna); BINCE (Benjamin); GRANDO (Sergei A.); BYSTRYN (Jean-Claude); WERTH (Victoria P.) |
| AF : | Department of Dermatology at St George Hospital, University of New South Wales/Sydney/Australie (1 aut., 2 aut.); Clinique Dermatologique, Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM U905, Rouen University Hospital, Dermatology Department, Rouen University Hospital, University of Rouen/France (3 aut.); Department of Dermatology, University Hospital of Bern/France (4 aut.); Keio University School of Medicine/Tokyo/Japon (5 aut.); Kurume University School of Medicine/Japon (6 aut.); Department of Dermatology, University of Paris XIII/Bobigny/France (7 aut.); Department of Dermatology and Venereology, Zagreb University Hospital Center and School of Medicine/Serbie (8 aut., 34 aut.); Department of Dermatology, State University of New York at Buffalo/Buffalo, New York/Etats-Unis (9 aut.); Department of Dermatology, University Hospital/Marburg/Afrique du Sud (10 aut.); Department of Oral Medicine, New York University College of Dentistry/Etats-Unis (12 aut.); Immunodermatology Departmentand/Italie (13 aut.); Laboratory of Molecular and Cell Biology,Instituto Dermopatico dell'Immacolata, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) IRCCS/Rome/Italie (21 aut.); Departments of Dermatology, University of Iowa and Department of Veterans Affairs Medical Center Iowa City/Etats-Unis (14 aut.); University Medical Center Groningen, University of Groningen/Allemagne (15 aut.); University of Texas Southwestern Medical Center/Etats-Unis (16 aut.); Department of Dermatology, University of North Carolina/Chapel Hill/Etats-Unis (17 aut., 24 aut., 33 aut.); Department of Dermatology, University of Luebeck/Etats-Unis (18 aut., 28 aut.); Department of Dermatology, Keck School of Medicine, University of Southern California/Etats-Unis (20 aut.); Department of Dermatology, University of Pennsylvania/Etats-Unis (19 aut., 38 aut.); Department of Dermatology, University of Sao Paulo/Etats-Unis (22 aut.); Institute of Dermatology, School of Biosciences and Biotechnologies, University of Modena and Reggio Emilia/Etats-Unis (23 aut.); Division of Dermatology, Duke Medical Center/Durham/Etats-Unis (25 aut.); Department of Dermatology, Hokkaido University Graduate School of Medicine/Sapporo/Japon (29 aut.); Carl Gustav Carus Medical School, Dresden University of Technology"/Allemagne (26 aut.); Department of Dermatology, University of Barcelona/Espagne (27 aut.) |
| DT : | Publication en série; Niveau analytique |
| SO : | Journal of the American Academy of Dermatology; ISSN 0190-9622; Coden JAADDB; Etats-Unis; Da. 2012; Vol. 66; No. 3; Pp. 479-485; Bibl. 10 ref. |
| LA : | Anglais |
| EA : | Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies. |
| CC : | 002B08E |
| FD : | Pemphigoïde bulleuse; Définition; Pronostic; Recommandation; Dermatologie |
| FG : | Dermatose bulleuse; Maladie autoimmune; Pathologie de la peau; Immunopathologie |
| ED : | Bullous pemphigoid; Definition; Prognosis; Recommendation; Dermatology |
| EG : | Bullous dermatosis; Autoimmune disease; Skin disease; Immunopathology |
| SD : | Penfigoide buloso; Definición; Pronóstico; Recomendación; Dermatología |
| LO : | INIST-18387.354000502871510180 |
| ID : | 12-0153002 |
Links to Exploration step
Pascal:12-0153002Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts</title><author><name sortKey="Murrell, Dedee F" sort="Murrell, Dedee F" uniqKey="Murrell D" first="Dedee F." last="Murrell">Dedee F. Murrell</name><affiliation><inist:fA14 i1="01"><s1>Department of Dermatology at St George Hospital, University of New South Wales</s1><s2>Sydney</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Daniel, Benjamin S" sort="Daniel, Benjamin S" uniqKey="Daniel B" first="Benjamin S." last="Daniel">Benjamin S. Daniel</name><affiliation><inist:fA14 i1="01"><s1>Department of Dermatology at St George Hospital, University of New South Wales</s1><s2>Sydney</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Joly, Pascal" sort="Joly, Pascal" uniqKey="Joly P" first="Pascal" last="Joly">Pascal Joly</name><affiliation><inist:fA14 i1="02"><s1>Clinique Dermatologique, Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM U905, Rouen University Hospital, Dermatology Department, Rouen University Hospital, University of Rouen</s1><s3>FRA</s3><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Borradori, Luca" sort="Borradori, Luca" uniqKey="Borradori L" first="Luca" last="Borradori">Luca Borradori</name><affiliation><inist:fA14 i1="03"><s1>Department of Dermatology, University Hospital of Bern</s1><s3>FRA</s3><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Amagai, Masayuki" sort="Amagai, Masayuki" uniqKey="Amagai M" first="Masayuki" last="Amagai">Masayuki Amagai</name><affiliation><inist:fA14 i1="04"><s1>Keio University School of Medicine</s1><s2>Tokyo</s2><s3>JPN</s3><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Hashimoto, Takashi" sort="Hashimoto, Takashi" uniqKey="Hashimoto T" first="Takashi" last="Hashimoto">Takashi Hashimoto</name><affiliation><inist:fA14 i1="05"><s1>Kurume University School of Medicine</s1><s3>JPN</s3><sZ>6 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Caux, Frederic" sort="Caux, Frederic" uniqKey="Caux F" first="Frederic" last="Caux">Frederic Caux</name><affiliation><inist:fA14 i1="06"><s1>Department of Dermatology, University of Paris XIII</s1><s2>Bobigny</s2><s3>FRA</s3><sZ>7 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Marinovic, Branka" sort="Marinovic, Branka" uniqKey="Marinovic B" first="Branka" last="Marinovic">Branka Marinovic</name><affiliation><inist:fA14 i1="07"><s1>Department of Dermatology and Venereology, Zagreb University Hospital Center and School of Medicine</s1><s3>SRB</s3><sZ>8 aut.</sZ><sZ>34 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Sinha, Animesh A" sort="Sinha, Animesh A" uniqKey="Sinha A" first="Animesh A." last="Sinha">Animesh A. Sinha</name><affiliation><inist:fA14 i1="08"><s1>Department of Dermatology, State University of New York at Buffalo</s1><s2>Buffalo, New York</s2><s3>USA</s3><sZ>9 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Hertl, Michael" sort="Hertl, Michael" uniqKey="Hertl M" first="Michael" last="Hertl">Michael Hertl</name><affiliation><inist:fA14 i1="09"><s1>Department of Dermatology, University Hospital</s1><s2>Marburg</s2><s3>ZAF</s3><sZ>10 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Bernard, Philippe" sort="Bernard, Philippe" uniqKey="Bernard P" first="Philippe" last="Bernard">Philippe Bernard</name></author><author><name sortKey="Sirois, David" sort="Sirois, David" uniqKey="Sirois D" first="David" last="Sirois">David Sirois</name><affiliation><inist:fA14 i1="10"><s1>Department of Oral Medicine, New York University College of Dentistry</s1><s3>USA</s3><sZ>12 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Cianchini, Giuseppe" sort="Cianchini, Giuseppe" uniqKey="Cianchini G" first="Giuseppe" last="Cianchini">Giuseppe Cianchini</name><affiliation><inist:fA14 i1="11"><s1>Immunodermatology Departmentand</s1><s3>ITA</s3><sZ>13 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Fairley, Janet A" sort="Fairley, Janet A" uniqKey="Fairley J" first="Janet A." last="Fairley">Janet A. Fairley</name><affiliation><inist:fA14 i1="13"><s1>Departments of Dermatology, University of Iowa and Department of Veterans Affairs Medical Center Iowa City</s1><s3>USA</s3><sZ>14 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Jonkman, Marcel F" sort="Jonkman, Marcel F" uniqKey="Jonkman M" first="Marcel F." last="Jonkman">Marcel F. Jonkman</name><affiliation><inist:fA14 i1="14"><s1>University Medical Center Groningen, University of Groningen</s1><s3>DEU</s3><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Pandya, Amit G" sort="Pandya, Amit G" uniqKey="Pandya A" first="Amit G." last="Pandya">Amit G. Pandya</name><affiliation><inist:fA14 i1="15"><s1>University of Texas Southwestern Medical Center</s1><s3>USA</s3><sZ>16 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Rubenstein, David" sort="Rubenstein, David" uniqKey="Rubenstein D" first="David" last="Rubenstein">David Rubenstein</name><affiliation><inist:fA14 i1="16"><s1>Department of Dermatology, University of North Carolina</s1><s2>Chapel Hill</s2><s3>USA</s3><sZ>17 aut.</sZ><sZ>24 aut.</sZ><sZ>33 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Zillikens, Detlef" sort="Zillikens, Detlef" uniqKey="Zillikens D" first="Detlef" last="Zillikens">Detlef Zillikens</name><affiliation><inist:fA14 i1="17"><s1>Department of Dermatology, University of Luebeck</s1><s3>USA</s3><sZ>18 aut.</sZ><sZ>28 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Payne, Aimee S" sort="Payne, Aimee S" uniqKey="Payne A" first="Aimee S." last="Payne">Aimee S. Payne</name><affiliation><inist:fA14 i1="19"><s1>Department of Dermatology, University of Pennsylvania</s1><s3>USA</s3><sZ>19 aut.</sZ><sZ>38 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Woodley, David" sort="Woodley, David" uniqKey="Woodley D" first="David" last="Woodley">David Woodley</name><affiliation><inist:fA14 i1="18"><s1>Department of Dermatology, Keck School of Medicine, University of Southern California</s1><s3>USA</s3><sZ>20 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Zambruno, Giovanna" sort="Zambruno, Giovanna" uniqKey="Zambruno G" first="Giovanna" last="Zambruno">Giovanna Zambruno</name><affiliation><inist:fA14 i1="12"><s1>Laboratory of Molecular and Cell Biology,Instituto Dermopatico dell'Immacolata, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) IRCCS</s1><s2>Rome</s2><s3>ITA</s3><sZ>21 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Aoki, Valeria" sort="Aoki, Valeria" uniqKey="Aoki V" first="Valeria" last="Aoki">Valeria Aoki</name><affiliation><inist:fA14 i1="20"><s1>Department of Dermatology, University of Sao Paulo</s1><s3>USA</s3><sZ>22 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Pincelli, Carlo" sort="Pincelli, Carlo" uniqKey="Pincelli C" first="Carlo" last="Pincelli">Carlo Pincelli</name><affiliation><inist:fA14 i1="21"><s1>Institute of Dermatology, School of Biosciences and Biotechnologies, University of Modena and Reggio Emilia</s1><s3>USA</s3><sZ>23 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Diaz, Luis" sort="Diaz, Luis" uniqKey="Diaz L" first="Luis" last="Diaz">Luis Diaz</name><affiliation><inist:fA14 i1="16"><s1>Department of Dermatology, University of North Carolina</s1><s2>Chapel Hill</s2><s3>USA</s3><sZ>17 aut.</sZ><sZ>24 aut.</sZ><sZ>33 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Hall, Russell P" sort="Hall, Russell P" uniqKey="Hall R" first="Russell P." last="Hall">Russell P. Hall</name><affiliation><inist:fA14 i1="22"><s1>Division of Dermatology, Duke Medical Center</s1><s2>Durham</s2><s3>USA</s3><sZ>25 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Meurer, Michael" sort="Meurer, Michael" uniqKey="Meurer M" first="Michael" last="Meurer">Michael Meurer</name><affiliation><inist:fA14 i1="24"><s1>Carl Gustav Carus Medical School, Dresden University of Technology"</s1><s3>DEU</s3><sZ>26 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Mascaro, Jose M Jr" sort="Mascaro, Jose M Jr" uniqKey="Mascaro J" first="Jose M. Jr" last="Mascaro">Jose M. Jr Mascaro</name><affiliation><inist:fA14 i1="25"><s1>Department of Dermatology, University of Barcelona</s1><s3>ESP</s3><sZ>27 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Schmidt, Enno" sort="Schmidt, Enno" uniqKey="Schmidt E" first="Enno" last="Schmidt">Enno Schmidt</name><affiliation><inist:fA14 i1="17"><s1>Department of Dermatology, University of Luebeck</s1><s3>USA</s3><sZ>18 aut.</sZ><sZ>28 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Shimizu, Hiroshi" sort="Shimizu, Hiroshi" uniqKey="Shimizu H" first="Hiroshi" last="Shimizu">Hiroshi Shimizu</name><affiliation><inist:fA14 i1="23"><s1>Department of Dermatology, Hokkaido University Graduate School of Medicine</s1><s2>Sapporo</s2><s3>JPN</s3><sZ>29 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Zone, John" sort="Zone, John" uniqKey="Zone J" first="John" last="Zone">John Zone</name></author><author><name sortKey="Swerlick, Robert" sort="Swerlick, Robert" uniqKey="Swerlick R" first="Robert" last="Swerlick">Robert Swerlick</name></author><author><name sortKey="Mimouni, Daniel" sort="Mimouni, Daniel" uniqKey="Mimouni D" first="Daniel" last="Mimouni">Daniel Mimouni</name></author><author><name sortKey="Culton, Donna" sort="Culton, Donna" uniqKey="Culton D" first="Donna" last="Culton">Donna Culton</name><affiliation><inist:fA14 i1="16"><s1>Department of Dermatology, University of North Carolina</s1><s2>Chapel Hill</s2><s3>USA</s3><sZ>17 aut.</sZ><sZ>24 aut.</sZ><sZ>33 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Lipozencic, Jasna" sort="Lipozencic, Jasna" uniqKey="Lipozencic J" first="Jasna" last="Lipozencic">Jasna Lipozencic</name><affiliation><inist:fA14 i1="07"><s1>Department of Dermatology and Venereology, Zagreb University Hospital Center and School of Medicine</s1><s3>SRB</s3><sZ>8 aut.</sZ><sZ>34 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Bince, Benjamin" sort="Bince, Benjamin" uniqKey="Bince B" first="Benjamin" last="Bince">Benjamin Bince</name></author><author><name sortKey="Grando, Sergei A" sort="Grando, Sergei A" uniqKey="Grando S" first="Sergei A." last="Grando">Sergei A. Grando</name></author><author><name sortKey="Bystryn, Jean Claude" sort="Bystryn, Jean Claude" uniqKey="Bystryn J" first="Jean-Claude" last="Bystryn">Jean-Claude Bystryn</name></author><author><name sortKey="Werth, Victoria P" sort="Werth, Victoria P" uniqKey="Werth V" first="Victoria P." last="Werth">Victoria P. Werth</name><affiliation><inist:fA14 i1="19"><s1>Department of Dermatology, University of Pennsylvania</s1><s3>USA</s3><sZ>19 aut.</sZ><sZ>38 aut.</sZ></inist:fA14></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">12-0153002</idno><date when="2012">2012</date><idno type="stanalyst">PASCAL 12-0153002 INIST</idno><idno type="RBID">Pascal:12-0153002</idno><idno type="wicri:Area/PascalFrancis/Corpus">001502</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts</title><author><name sortKey="Murrell, Dedee F" sort="Murrell, Dedee F" uniqKey="Murrell D" first="Dedee F." last="Murrell">Dedee F. Murrell</name><affiliation><inist:fA14 i1="01"><s1>Department of Dermatology at St George Hospital, University of New South Wales</s1><s2>Sydney</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Daniel, Benjamin S" sort="Daniel, Benjamin S" uniqKey="Daniel B" first="Benjamin S." last="Daniel">Benjamin S. Daniel</name><affiliation><inist:fA14 i1="01"><s1>Department of Dermatology at St George Hospital, University of New South Wales</s1><s2>Sydney</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Joly, Pascal" sort="Joly, Pascal" uniqKey="Joly P" first="Pascal" last="Joly">Pascal Joly</name><affiliation><inist:fA14 i1="02"><s1>Clinique Dermatologique, Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM U905, Rouen University Hospital, Dermatology Department, Rouen University Hospital, University of Rouen</s1><s3>FRA</s3><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Borradori, Luca" sort="Borradori, Luca" uniqKey="Borradori L" first="Luca" last="Borradori">Luca Borradori</name><affiliation><inist:fA14 i1="03"><s1>Department of Dermatology, University Hospital of Bern</s1><s3>FRA</s3><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Amagai, Masayuki" sort="Amagai, Masayuki" uniqKey="Amagai M" first="Masayuki" last="Amagai">Masayuki Amagai</name><affiliation><inist:fA14 i1="04"><s1>Keio University School of Medicine</s1><s2>Tokyo</s2><s3>JPN</s3><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Hashimoto, Takashi" sort="Hashimoto, Takashi" uniqKey="Hashimoto T" first="Takashi" last="Hashimoto">Takashi Hashimoto</name><affiliation><inist:fA14 i1="05"><s1>Kurume University School of Medicine</s1><s3>JPN</s3><sZ>6 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Caux, Frederic" sort="Caux, Frederic" uniqKey="Caux F" first="Frederic" last="Caux">Frederic Caux</name><affiliation><inist:fA14 i1="06"><s1>Department of Dermatology, University of Paris XIII</s1><s2>Bobigny</s2><s3>FRA</s3><sZ>7 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Marinovic, Branka" sort="Marinovic, Branka" uniqKey="Marinovic B" first="Branka" last="Marinovic">Branka Marinovic</name><affiliation><inist:fA14 i1="07"><s1>Department of Dermatology and Venereology, Zagreb University Hospital Center and School of Medicine</s1><s3>SRB</s3><sZ>8 aut.</sZ><sZ>34 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Sinha, Animesh A" sort="Sinha, Animesh A" uniqKey="Sinha A" first="Animesh A." last="Sinha">Animesh A. Sinha</name><affiliation><inist:fA14 i1="08"><s1>Department of Dermatology, State University of New York at Buffalo</s1><s2>Buffalo, New York</s2><s3>USA</s3><sZ>9 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Hertl, Michael" sort="Hertl, Michael" uniqKey="Hertl M" first="Michael" last="Hertl">Michael Hertl</name><affiliation><inist:fA14 i1="09"><s1>Department of Dermatology, University Hospital</s1><s2>Marburg</s2><s3>ZAF</s3><sZ>10 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Bernard, Philippe" sort="Bernard, Philippe" uniqKey="Bernard P" first="Philippe" last="Bernard">Philippe Bernard</name></author><author><name sortKey="Sirois, David" sort="Sirois, David" uniqKey="Sirois D" first="David" last="Sirois">David Sirois</name><affiliation><inist:fA14 i1="10"><s1>Department of Oral Medicine, New York University College of Dentistry</s1><s3>USA</s3><sZ>12 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Cianchini, Giuseppe" sort="Cianchini, Giuseppe" uniqKey="Cianchini G" first="Giuseppe" last="Cianchini">Giuseppe Cianchini</name><affiliation><inist:fA14 i1="11"><s1>Immunodermatology Departmentand</s1><s3>ITA</s3><sZ>13 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Fairley, Janet A" sort="Fairley, Janet A" uniqKey="Fairley J" first="Janet A." last="Fairley">Janet A. Fairley</name><affiliation><inist:fA14 i1="13"><s1>Departments of Dermatology, University of Iowa and Department of Veterans Affairs Medical Center Iowa City</s1><s3>USA</s3><sZ>14 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Jonkman, Marcel F" sort="Jonkman, Marcel F" uniqKey="Jonkman M" first="Marcel F." last="Jonkman">Marcel F. Jonkman</name><affiliation><inist:fA14 i1="14"><s1>University Medical Center Groningen, University of Groningen</s1><s3>DEU</s3><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Pandya, Amit G" sort="Pandya, Amit G" uniqKey="Pandya A" first="Amit G." last="Pandya">Amit G. Pandya</name><affiliation><inist:fA14 i1="15"><s1>University of Texas Southwestern Medical Center</s1><s3>USA</s3><sZ>16 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Rubenstein, David" sort="Rubenstein, David" uniqKey="Rubenstein D" first="David" last="Rubenstein">David Rubenstein</name><affiliation><inist:fA14 i1="16"><s1>Department of Dermatology, University of North Carolina</s1><s2>Chapel Hill</s2><s3>USA</s3><sZ>17 aut.</sZ><sZ>24 aut.</sZ><sZ>33 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Zillikens, Detlef" sort="Zillikens, Detlef" uniqKey="Zillikens D" first="Detlef" last="Zillikens">Detlef Zillikens</name><affiliation><inist:fA14 i1="17"><s1>Department of Dermatology, University of Luebeck</s1><s3>USA</s3><sZ>18 aut.</sZ><sZ>28 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Payne, Aimee S" sort="Payne, Aimee S" uniqKey="Payne A" first="Aimee S." last="Payne">Aimee S. Payne</name><affiliation><inist:fA14 i1="19"><s1>Department of Dermatology, University of Pennsylvania</s1><s3>USA</s3><sZ>19 aut.</sZ><sZ>38 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Woodley, David" sort="Woodley, David" uniqKey="Woodley D" first="David" last="Woodley">David Woodley</name><affiliation><inist:fA14 i1="18"><s1>Department of Dermatology, Keck School of Medicine, University of Southern California</s1><s3>USA</s3><sZ>20 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Zambruno, Giovanna" sort="Zambruno, Giovanna" uniqKey="Zambruno G" first="Giovanna" last="Zambruno">Giovanna Zambruno</name><affiliation><inist:fA14 i1="12"><s1>Laboratory of Molecular and Cell Biology,Instituto Dermopatico dell'Immacolata, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) IRCCS</s1><s2>Rome</s2><s3>ITA</s3><sZ>21 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Aoki, Valeria" sort="Aoki, Valeria" uniqKey="Aoki V" first="Valeria" last="Aoki">Valeria Aoki</name><affiliation><inist:fA14 i1="20"><s1>Department of Dermatology, University of Sao Paulo</s1><s3>USA</s3><sZ>22 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Pincelli, Carlo" sort="Pincelli, Carlo" uniqKey="Pincelli C" first="Carlo" last="Pincelli">Carlo Pincelli</name><affiliation><inist:fA14 i1="21"><s1>Institute of Dermatology, School of Biosciences and Biotechnologies, University of Modena and Reggio Emilia</s1><s3>USA</s3><sZ>23 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Diaz, Luis" sort="Diaz, Luis" uniqKey="Diaz L" first="Luis" last="Diaz">Luis Diaz</name><affiliation><inist:fA14 i1="16"><s1>Department of Dermatology, University of North Carolina</s1><s2>Chapel Hill</s2><s3>USA</s3><sZ>17 aut.</sZ><sZ>24 aut.</sZ><sZ>33 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Hall, Russell P" sort="Hall, Russell P" uniqKey="Hall R" first="Russell P." last="Hall">Russell P. Hall</name><affiliation><inist:fA14 i1="22"><s1>Division of Dermatology, Duke Medical Center</s1><s2>Durham</s2><s3>USA</s3><sZ>25 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Meurer, Michael" sort="Meurer, Michael" uniqKey="Meurer M" first="Michael" last="Meurer">Michael Meurer</name><affiliation><inist:fA14 i1="24"><s1>Carl Gustav Carus Medical School, Dresden University of Technology"</s1><s3>DEU</s3><sZ>26 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Mascaro, Jose M Jr" sort="Mascaro, Jose M Jr" uniqKey="Mascaro J" first="Jose M. Jr" last="Mascaro">Jose M. Jr Mascaro</name><affiliation><inist:fA14 i1="25"><s1>Department of Dermatology, University of Barcelona</s1><s3>ESP</s3><sZ>27 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Schmidt, Enno" sort="Schmidt, Enno" uniqKey="Schmidt E" first="Enno" last="Schmidt">Enno Schmidt</name><affiliation><inist:fA14 i1="17"><s1>Department of Dermatology, University of Luebeck</s1><s3>USA</s3><sZ>18 aut.</sZ><sZ>28 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Shimizu, Hiroshi" sort="Shimizu, Hiroshi" uniqKey="Shimizu H" first="Hiroshi" last="Shimizu">Hiroshi Shimizu</name><affiliation><inist:fA14 i1="23"><s1>Department of Dermatology, Hokkaido University Graduate School of Medicine</s1><s2>Sapporo</s2><s3>JPN</s3><sZ>29 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Zone, John" sort="Zone, John" uniqKey="Zone J" first="John" last="Zone">John Zone</name></author><author><name sortKey="Swerlick, Robert" sort="Swerlick, Robert" uniqKey="Swerlick R" first="Robert" last="Swerlick">Robert Swerlick</name></author><author><name sortKey="Mimouni, Daniel" sort="Mimouni, Daniel" uniqKey="Mimouni D" first="Daniel" last="Mimouni">Daniel Mimouni</name></author><author><name sortKey="Culton, Donna" sort="Culton, Donna" uniqKey="Culton D" first="Donna" last="Culton">Donna Culton</name><affiliation><inist:fA14 i1="16"><s1>Department of Dermatology, University of North Carolina</s1><s2>Chapel Hill</s2><s3>USA</s3><sZ>17 aut.</sZ><sZ>24 aut.</sZ><sZ>33 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Lipozencic, Jasna" sort="Lipozencic, Jasna" uniqKey="Lipozencic J" first="Jasna" last="Lipozencic">Jasna Lipozencic</name><affiliation><inist:fA14 i1="07"><s1>Department of Dermatology and Venereology, Zagreb University Hospital Center and School of Medicine</s1><s3>SRB</s3><sZ>8 aut.</sZ><sZ>34 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Bince, Benjamin" sort="Bince, Benjamin" uniqKey="Bince B" first="Benjamin" last="Bince">Benjamin Bince</name></author><author><name sortKey="Grando, Sergei A" sort="Grando, Sergei A" uniqKey="Grando S" first="Sergei A." last="Grando">Sergei A. Grando</name></author><author><name sortKey="Bystryn, Jean Claude" sort="Bystryn, Jean Claude" uniqKey="Bystryn J" first="Jean-Claude" last="Bystryn">Jean-Claude Bystryn</name></author><author><name sortKey="Werth, Victoria P" sort="Werth, Victoria P" uniqKey="Werth V" first="Victoria P." last="Werth">Victoria P. Werth</name><affiliation><inist:fA14 i1="19"><s1>Department of Dermatology, University of Pennsylvania</s1><s3>USA</s3><sZ>19 aut.</sZ><sZ>38 aut.</sZ></inist:fA14></affiliation></author></analytic><series><title level="j" type="main">Journal of the American Academy of Dermatology</title><title level="j" type="abbreviated">J. Am. Acad. Dermatol.</title><idno type="ISSN">0190-9622</idno><imprint><date when="2012">2012</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Journal of the American Academy of Dermatology</title><title level="j" type="abbreviated">J. Am. Acad. Dermatol.</title><idno type="ISSN">0190-9622</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Bullous pemphigoid</term><term>Definition</term><term>Dermatology</term><term>Prognosis</term><term>Recommendation</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Pemphigoïde bulleuse</term><term>Définition</term><term>Pronostic</term><term>Recommandation</term><term>Dermatologie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0190-9622</s0></fA01><fA02 i1="01"><s0>JAADDB</s0></fA02><fA03 i2="1"><s0>J. Am. Acad. Dermatol.</s0></fA03><fA05><s2>66</s2></fA05><fA06><s2>3</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts</s1></fA08><fA11 i1="01" i2="1"><s1>MURRELL (Dedee F.)</s1></fA11><fA11 i1="02" i2="1"><s1>DANIEL (Benjamin S.)</s1></fA11><fA11 i1="03" i2="1"><s1>JOLY (Pascal)</s1></fA11><fA11 i1="04" i2="1"><s1>BORRADORI (Luca)</s1></fA11><fA11 i1="05" i2="1"><s1>AMAGAI (Masayuki)</s1></fA11><fA11 i1="06" i2="1"><s1>HASHIMOTO (Takashi)</s1></fA11><fA11 i1="07" i2="1"><s1>CAUX (Frederic)</s1></fA11><fA11 i1="08" i2="1"><s1>MARINOVIC (Branka)</s1></fA11><fA11 i1="09" i2="1"><s1>SINHA (Animesh A.)</s1></fA11><fA11 i1="10" i2="1"><s1>HERTL (Michael)</s1></fA11><fA11 i1="11" i2="1"><s1>BERNARD (Philippe)</s1></fA11><fA11 i1="12" i2="1"><s1>SIROIS (David)</s1></fA11><fA11 i1="13" i2="1"><s1>CIANCHINI (Giuseppe)</s1></fA11><fA11 i1="14" i2="1"><s1>FAIRLEY (Janet A.)</s1></fA11><fA11 i1="15" i2="1"><s1>JONKMAN (Marcel F.)</s1></fA11><fA11 i1="16" i2="1"><s1>PANDYA (Amit G.)</s1></fA11><fA11 i1="17" i2="1"><s1>RUBENSTEIN (David)</s1></fA11><fA11 i1="18" i2="1"><s1>ZILLIKENS (Detlef)</s1></fA11><fA11 i1="19" i2="1"><s1>PAYNE (Aimee S.)</s1></fA11><fA11 i1="20" i2="1"><s1>WOODLEY (David)</s1></fA11><fA11 i1="21" i2="1"><s1>ZAMBRUNO (Giovanna)</s1></fA11><fA11 i1="22" i2="1"><s1>AOKI (Valeria)</s1></fA11><fA11 i1="23" i2="1"><s1>PINCELLI (Carlo)</s1></fA11><fA11 i1="24" i2="1"><s1>DIAZ (Luis)</s1></fA11><fA11 i1="25" i2="1"><s1>HALL (Russell P.)</s1></fA11><fA11 i1="26" i2="1"><s1>MEURER (Michael)</s1></fA11><fA11 i1="27" i2="1"><s1>MASCARO (Jose M. JR)</s1></fA11><fA11 i1="28" i2="1"><s1>SCHMIDT (Enno)</s1></fA11><fA11 i1="29" i2="1"><s1>SHIMIZU (Hiroshi)</s1></fA11><fA11 i1="30" i2="1"><s1>ZONE (John)</s1></fA11><fA11 i1="31" i2="1"><s1>SWERLICK (Robert)</s1></fA11><fA11 i1="32" i2="1"><s1>MIMOUNI (Daniel)</s1></fA11><fA11 i1="33" i2="1"><s1>CULTON (Donna)</s1></fA11><fA11 i1="34" i2="1"><s1>LIPOZENCIC (Jasna)</s1></fA11><fA11 i1="35" i2="1"><s1>BINCE (Benjamin)</s1></fA11><fA11 i1="36" i2="1"><s1>GRANDO (Sergei A.)</s1></fA11><fA11 i1="37" i2="1"><s1>BYSTRYN (Jean-Claude)</s1></fA11><fA11 i1="38" i2="1"><s1>WERTH (Victoria P.)</s1></fA11><fA14 i1="01"><s1>Department of Dermatology at St George Hospital, University of New South Wales</s1><s2>Sydney</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></fA14><fA14 i1="02"><s1>Clinique Dermatologique, Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM U905, Rouen University Hospital, Dermatology Department, Rouen University Hospital, University of Rouen</s1><s3>FRA</s3><sZ>3 aut.</sZ></fA14><fA14 i1="03"><s1>Department of Dermatology, University Hospital of Bern</s1><s3>FRA</s3><sZ>4 aut.</sZ></fA14><fA14 i1="04"><s1>Keio University School of Medicine</s1><s2>Tokyo</s2><s3>JPN</s3><sZ>5 aut.</sZ></fA14><fA14 i1="05"><s1>Kurume University School of Medicine</s1><s3>JPN</s3><sZ>6 aut.</sZ></fA14><fA14 i1="06"><s1>Department of Dermatology, University of Paris XIII</s1><s2>Bobigny</s2><s3>FRA</s3><sZ>7 aut.</sZ></fA14><fA14 i1="07"><s1>Department of Dermatology and Venereology, Zagreb University Hospital Center and School of Medicine</s1><s3>SRB</s3><sZ>8 aut.</sZ><sZ>34 aut.</sZ></fA14><fA14 i1="08"><s1>Department of Dermatology, State University of New York at Buffalo</s1><s2>Buffalo, New York</s2><s3>USA</s3><sZ>9 aut.</sZ></fA14><fA14 i1="09"><s1>Department of Dermatology, University Hospital</s1><s2>Marburg</s2><s3>ZAF</s3><sZ>10 aut.</sZ></fA14><fA14 i1="10"><s1>Department of Oral Medicine, New York University College of Dentistry</s1><s3>USA</s3><sZ>12 aut.</sZ></fA14><fA14 i1="11"><s1>Immunodermatology Departmentand</s1><s3>ITA</s3><sZ>13 aut.</sZ></fA14><fA14 i1="12"><s1>Laboratory of Molecular and Cell Biology,Instituto Dermopatico dell'Immacolata, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) IRCCS</s1><s2>Rome</s2><s3>ITA</s3><sZ>21 aut.</sZ></fA14><fA14 i1="13"><s1>Departments of Dermatology, University of Iowa and Department of Veterans Affairs Medical Center Iowa City</s1><s3>USA</s3><sZ>14 aut.</sZ></fA14><fA14 i1="14"><s1>University Medical Center Groningen, University of Groningen</s1><s3>DEU</s3><sZ>15 aut.</sZ></fA14><fA14 i1="15"><s1>University of Texas Southwestern Medical Center</s1><s3>USA</s3><sZ>16 aut.</sZ></fA14><fA14 i1="16"><s1>Department of Dermatology, University of North Carolina</s1><s2>Chapel Hill</s2><s3>USA</s3><sZ>17 aut.</sZ><sZ>24 aut.</sZ><sZ>33 aut.</sZ></fA14><fA14 i1="17"><s1>Department of Dermatology, University of Luebeck</s1><s3>USA</s3><sZ>18 aut.</sZ><sZ>28 aut.</sZ></fA14><fA14 i1="18"><s1>Department of Dermatology, Keck School of Medicine, University of Southern California</s1><s3>USA</s3><sZ>20 aut.</sZ></fA14><fA14 i1="19"><s1>Department of Dermatology, University of Pennsylvania</s1><s3>USA</s3><sZ>19 aut.</sZ><sZ>38 aut.</sZ></fA14><fA14 i1="20"><s1>Department of Dermatology, University of Sao Paulo</s1><s3>USA</s3><sZ>22 aut.</sZ></fA14><fA14 i1="21"><s1>Institute of Dermatology, School of Biosciences and Biotechnologies, University of Modena and Reggio Emilia</s1><s3>USA</s3><sZ>23 aut.</sZ></fA14><fA14 i1="22"><s1>Division of Dermatology, Duke Medical Center</s1><s2>Durham</s2><s3>USA</s3><sZ>25 aut.</sZ></fA14><fA14 i1="23"><s1>Department of Dermatology, Hokkaido University Graduate School of Medicine</s1><s2>Sapporo</s2><s3>JPN</s3><sZ>29 aut.</sZ></fA14><fA14 i1="24"><s1>Carl Gustav Carus Medical School, Dresden University of Technology"</s1><s3>DEU</s3><sZ>26 aut.</sZ></fA14><fA14 i1="25"><s1>Department of Dermatology, University of Barcelona</s1><s3>ESP</s3><sZ>27 aut.</sZ></fA14><fA20><s1>479-485</s1></fA20><fA21><s1>2012</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>18387</s2><s5>354000502871510180</s5></fA43><fA44><s0>0000</s0><s1>© 2012 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>10 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>12-0153002</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Journal of the American Academy of Dermatology</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies.</s0></fC01><fC02 i1="01" i2="X"><s0>002B08E</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Pemphigoïde bulleuse</s0><s2>NM</s2><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Bullous pemphigoid</s0><s2>NM</s2><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Penfigoide buloso</s0><s2>NM</s2><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Définition</s0><s5>07</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Definition</s0><s5>07</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Definición</s0><s5>07</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Pronostic</s0><s5>08</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Prognosis</s0><s5>08</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Pronóstico</s0><s5>08</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Recommandation</s0><s5>09</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Recommendation</s0><s5>09</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Recomendación</s0><s5>09</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Dermatologie</s0><s5>13</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Dermatology</s0><s5>13</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Dermatología</s0><s5>13</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Dermatose bulleuse</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Bullous dermatosis</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Dermatosis bulosa</s0><s5>37</s5></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Maladie autoimmune</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Autoimmune disease</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Enfermedad autoinmune</s0><s5>38</s5></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Pathologie de la peau</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Skin disease</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Piel patología</s0><s5>39</s5></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Immunopathologie</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Immunopathology</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Inmunopatología</s0><s5>40</s5></fC07><fN21><s1>114</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard><server><NO>PASCAL 12-0153002 INIST</NO><ET>Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts</ET><AU>MURRELL (Dedee F.); DANIEL (Benjamin S.); JOLY (Pascal); BORRADORI (Luca); AMAGAI (Masayuki); HASHIMOTO (Takashi); CAUX (Frederic); MARINOVIC (Branka); SINHA (Animesh A.); HERTL (Michael); BERNARD (Philippe); SIROIS (David); CIANCHINI (Giuseppe); FAIRLEY (Janet A.); JONKMAN (Marcel F.); PANDYA (Amit G.); RUBENSTEIN (David); ZILLIKENS (Detlef); PAYNE (Aimee S.); WOODLEY (David); ZAMBRUNO (Giovanna); AOKI (Valeria); PINCELLI (Carlo); DIAZ (Luis); HALL (Russell P.); MEURER (Michael); MASCARO (Jose M. JR); SCHMIDT (Enno); SHIMIZU (Hiroshi); ZONE (John); SWERLICK (Robert); MIMOUNI (Daniel); CULTON (Donna); LIPOZENCIC (Jasna); BINCE (Benjamin); GRANDO (Sergei A.); BYSTRYN (Jean-Claude); WERTH (Victoria P.)</AU><AF>Department of Dermatology at St George Hospital, University of New South Wales/Sydney/Australie (1 aut., 2 aut.); Clinique Dermatologique, Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM U905, Rouen University Hospital, Dermatology Department, Rouen University Hospital, University of Rouen/France (3 aut.); Department of Dermatology, University Hospital of Bern/France (4 aut.); Keio University School of Medicine/Tokyo/Japon (5 aut.); Kurume University School of Medicine/Japon (6 aut.); Department of Dermatology, University of Paris XIII/Bobigny/France (7 aut.); Department of Dermatology and Venereology, Zagreb University Hospital Center and School of Medicine/Serbie (8 aut., 34 aut.); Department of Dermatology, State University of New York at Buffalo/Buffalo, New York/Etats-Unis (9 aut.); Department of Dermatology, University Hospital/Marburg/Afrique du Sud (10 aut.); Department of Oral Medicine, New York University College of Dentistry/Etats-Unis (12 aut.); Immunodermatology Departmentand/Italie (13 aut.); Laboratory of Molecular and Cell Biology,Instituto Dermopatico dell'Immacolata, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) IRCCS/Rome/Italie (21 aut.); Departments of Dermatology, University of Iowa and Department of Veterans Affairs Medical Center Iowa City/Etats-Unis (14 aut.); University Medical Center Groningen, University of Groningen/Allemagne (15 aut.); University of Texas Southwestern Medical Center/Etats-Unis (16 aut.); Department of Dermatology, University of North Carolina/Chapel Hill/Etats-Unis (17 aut., 24 aut., 33 aut.); Department of Dermatology, University of Luebeck/Etats-Unis (18 aut., 28 aut.); Department of Dermatology, Keck School of Medicine, University of Southern California/Etats-Unis (20 aut.); Department of Dermatology, University of Pennsylvania/Etats-Unis (19 aut., 38 aut.); Department of Dermatology, University of Sao Paulo/Etats-Unis (22 aut.); Institute of Dermatology, School of Biosciences and Biotechnologies, University of Modena and Reggio Emilia/Etats-Unis (23 aut.); Division of Dermatology, Duke Medical Center/Durham/Etats-Unis (25 aut.); Department of Dermatology, Hokkaido University Graduate School of Medicine/Sapporo/Japon (29 aut.); Carl Gustav Carus Medical School, Dresden University of Technology"/Allemagne (26 aut.); Department of Dermatology, University of Barcelona/Espagne (27 aut.)</AF><DT>Publication en série; Niveau analytique</DT><SO>Journal of the American Academy of Dermatology; ISSN 0190-9622; Coden JAADDB; Etats-Unis; Da. 2012; Vol. 66; No. 3; Pp. 479-485; Bibl. 10 ref.</SO><LA>Anglais</LA><EA>Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies.</EA><CC>002B08E</CC><FD>Pemphigoïde bulleuse; Définition; Pronostic; Recommandation; Dermatologie</FD><FG>Dermatose bulleuse; Maladie autoimmune; Pathologie de la peau; Immunopathologie</FG><ED>Bullous pemphigoid; Definition; Prognosis; Recommendation; Dermatology</ED><EG>Bullous dermatosis; Autoimmune disease; Skin disease; Immunopathology</EG><SD>Penfigoide buloso; Definición; Pronóstico; Recomendación; Dermatología</SD><LO>INIST-18387.354000502871510180</LO><ID>12-0153002</ID></server></inist></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001502 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001502 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:12-0153002
|texte= Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
}}
| This area was generated with Dilib version V0.6.33. |  |